跳至主要内容
临床试验/NCT07056582
NCT07056582招募中不适用

Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries

Sohag University1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2025年4月14日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
105
试验地点
1
主要终点
This study aims to assess the efficacy of nebulized dexmedetomidine vs nebulized ketamine to achieve good postoperative pain management in patients undergoing endoscopic nasal surgeries.

研究概览

简要总结

this study aims to compare the efficacy of pre-emptive nebulized ketamine versus nebulized dexmedetomidine for post operative pain relief in endoscopic nasal surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients between the ages of 20 and 60,
  • both sexes,
  • American Society of Anesthesiologists physical status I to II
  • BMI ≥18≤30 kg/m²

排除标准

  • Patient refusal.
  • patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
  • patients with a history of allergies to any study drugs.
  • patients who had used central nervous system depressants or analgesics within the previous 24 hours.
  • patients with hypertension, hypotension, or bradycardia.

研究组 & 干预措施

group D : will receive dexmedetomidine

Active Comparator

Patients will receive nebulized dexmedetomidine 50 μg (0.5 ml +normal saline 0.9% up to 3 ml) 15 minutes prior to the onset of surgery.

干预措施: Dexmedetomidine (Drug)

group K : will receive ketamine

Active Comparator

patients will receive nebulized ketamine 50 mg (1 ml + normal saline 0.9%up to 3 ml) 15 minutes prior to the onset of surgery.

干预措施: Ketamine (Drug)

group C: will receive .9% saline

Placebo Comparator

Patients will receive nebulized normal saline 0.9% (3 ml) 15 minutes prior to the onset of surgery.

干预措施: 0.9%sodium chloride (Drug)

结局指标

主要结局

This study aims to assess the efficacy of nebulized dexmedetomidine vs nebulized ketamine to achieve good postoperative pain management in patients undergoing endoscopic nasal surgeries.

时间窗: 24 hours after operation

post operative pain management by VAS

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Thabet Abdelhameed

Resident , Anesthesia , Surgical Icu , Pain management Faculty of Medicine Sohag university

Sohag University

研究点 (1)

Loading locations...

相似试验